Method and apparatus for locating the injection point of an implanted medical device
First Claim
Patent Images
1. An implantable drug port, comprising:
- a low profile housing, comprising a port top and a port base, wherein the low profile port base further comprises a low profile port stem;
a septum disposed within the housing, wherein a lumen is defined within the housing beneath the septum and accessible through the septum; and
at least two indicators disposed on the housing, spaced apart along an axis of the housing.
1 Assignment
0 Petitions
Accused Products
Abstract
A method and apparatus for locating the injection point of an implanted medical device. In a preferred embodiment, the locating apparatus is in the form of radiopaque rings made of a metallic substance. When these rings are spaced apart at different heights on an implanted medical device, such as a drug port, a stereoscopic effect results from fluoroscopically viewing the device along an axis not parallel to the axis along which the rings are spaced. This effect allows one to readily determine the orientation of the device. This prevents accidental injection of drugs into the hard backside of the drug port.
223 Citations
31 Claims
-
1. An implantable drug port, comprising:
-
a low profile housing, comprising a port top and a port base, wherein the low profile port base further comprises a low profile port stem;
a septum disposed within the housing, wherein a lumen is defined within the housing beneath the septum and accessible through the septum; and
at least two indicators disposed on the housing, spaced apart along an axis of the housing. - View Dependent Claims (2, 3, 4, 5, 6, 7, 9, 10, 11, 13, 14)
8.The implantable drug port according to claim 7, wherein said plurality of rings further comprises a lower ring of a first diameter disposed near a bottom of said drug port and an upper ring of a second diameter, different from said first diameter, disposed near a top of said drug port. -
9. The implantable drug port according to claim 7, wherein said plurality of rings are comprised of a metal selected from the group consisting of stainless steel, gold, platinum, tungsten tantalum and titanium.
-
10. The implantable drug port according to claim 7, wherein said plurality of rings are comprised of a resin and a powdered material selected from the group consisting of stainless steel, gold, platinum, tungsten tantalum, titanium and a barium compound.
-
11. The implantable drug port according to claim 1, wherein the indicators comprise a lower locator ring and an upper locator ring, wherein the lower locator ring is interrupted creating a discontinuity, and is disposed at a bottom of said low profile housing such that the discontinuity is aligned with the port stem, and wherein the upper locator ring is placed between the septum and the port top.
-
13. The implantable drug port according to claim 1, further comprising a radiopaque catheter connected to the port stem.
-
14. The implantable drug port according to claim 1, wherein the indicators are formed to be distinguishable from each other by imaging when said drug port is implanted.
-
-
8. The implantable drug port according to claim 8, wherein said lower ring is interrupted creating a discontinuity.
-
12. The implantable drug port according to claim 12, wherein the low profile housing is encapsulated with a silicone rubber material.
-
15. A method for determining an orientation of an implantable drug port to assist in guiding a needle into the port, wherein the implantable drug port comprises a non-inflatable housing having a first and second side, a septum disposed within the housing and a first and second indicator spaced apart along a first axis of the housing comprising the steps of:
-
locating the implanted non-inflatable housing;
imaging the housing along a second axis not parallel to the first axis; and
determining the orientation of the housing with respect to the first and second sides.
-
- 16. The method according to claim 16, wherein said indicators comprise radiopaque material.
- 17. The method according to claim 17, wherein said radiopaque material is selected from the group consisting of gold, platinum, tungsten, tantalum, stainless steel, titanium and barium compounds.
- 20. The method according to claim 20, wherein said ring shaped indicator is interrupted creating a discontinuity.
-
22. A method for guiding a needle into an implantable drug port, comprising the steps of:
-
providing a drug port comprising a non-inflatable housing, a septum disposed within the housing and a first and second indicator spaced apart along a first axis of the housing, wherein the indicators are distinguishable, one from the other, by an imaging technique;
implanting the drug port with the first axis normal to a patient'"'"'s skin surface;
employing the imaging technique to image the drug port along a second axis not parallel to the first axis;
determining the orientation of the drug port based on an imaged spatial relationship of the first indicator to the second indicator; and
inserting the needle into the septum at a location where the septum is accessible.
-
-
23. An implantable drug port, comprising:
-
a housing;
a septum disposed within the housing, wherein a lumen is defined within the housing beneath the septum and accessible through the septum; and
indicators associated with the housing, comprising a lower locator ring and an upper locator ring, wherein the rings are spaced apart along an axis of the housing, and wherein at least one of the rings is interrupted creating a discontinuity.
-
- 24. The implantable drug port according to claim 24, wherein the rings are formed from radiopaque material.
- 25. The implantable drug port according to claim 25, wherein the radiopaque material is a metal selected from the group consisting of stainless steel, gold, platinum, tungsten tantalum and titanium.
-
31. The implantable drug port according to claim 31, further comprising a radiopaque catheter, wherein the radiopaque catheter is connected to the port stem.
Specification